AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
45 hedge funds and large institutions have $18.4M invested in Agile Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less capital invested
Capital invested by funds: $30.5M → $18.4M (-$12.2M)
Holders
45
Holding in Top 10
1
Calls
$177K
Puts
–
Top Buyers
| 1 | +$2.62M | |
| 2 | +$898K | |
| 3 | +$190K | |
| 4 |
VF
Virtu Financial
New York
|
+$102K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$72.2K |
Top Sellers
| 1 | -$399K | |
| 2 | -$215K | |
| 3 | -$203K | |
| 4 |
NIM
Needham Investment Management
New York
|
-$189K |
| 5 |
SGI
Summit Global Investments
Bountiful,
Utah
|
-$121K |